Re: [177Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial
Emmett L, Subramaniam S, Crumbaker M, et al
Related Articles
Christina Ching, MD, on predictors of follow-up after pediatric stone surgery
“Interestingly, the patients that were more likely to follow-up were those patients that were seen and established within our urology clinic,” says Christina B. Ching,…
SGLT2 Inhibitors Confer Greater Cardioprotective Effect in Older Adults With T2D
SGLT2 inhibitors were associated with better cardioprotective effects among older adults than younger adults with type 2 diabetes.
One-Hour Glucose on OGTT at 3 Months Postpartum Predicts Dysglycemia
One-hour glucose was strongest predictor of dysglycemia on regression analyses, followed by 2-hour glucose
EAU Guidelines on Prostate Cancer – DIAGNOSTIC EVALUATION – Uroweb
The Prostate Cancer (PCa) Guidelines Panel have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa.
Study Reveals Link Between Forever Chemicals and Childhood Cancers
Findings based on prenatal maternal exposure in drinking water
SGLT2 Inhibitors May Lower Stone Risk in Patients Regardless of Stone History
This is the first study examining possible SGLT2 inhibitor benefits in recurrent stone formers.
Adding ADT to SBRT improves progression-free survival in oligorecurrent HSPC
“Considering that almost all patients in the combined treatment group achieved testosterone recovery at 1 year, the results support that this short term (intermittent) combined…
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial ‘Omics in Uro-oncology
This work explores the potential of spatial omics to improve our understanding of the underlying biology of urological cancers, with the aim of improving prediction,…
Wearable Furosemide Delivery System Approved for CKD Patients
The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with chronic kidney…
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
“In terms of how I select patients, I really look at the timing of metastatic disease, so whether it’s metachronous or synchronous and the volume,…